- Home
- LYEL vs WNEB Comparison
LYEL vs WNEB Comparison
Compare LYEL & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- WNEB
- Stock Information
- Founded
- LYEL 2018
- WNEB 1853
- Country
- LYEL United States
- WNEB United States
- Employees
- LYEL N/A
- WNEB N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- WNEB Savings Institutions
- Sector
- LYEL Health Care
- WNEB Finance
- Exchange
- LYEL Nasdaq
- WNEB Nasdaq
- Market Cap
- LYEL 207.7M
- WNEB 195.7M
- IPO Year
- LYEL 2021
- WNEB N/A
- Fundamental
- Price
- LYEL $12.82
- WNEB $12.20
- Analyst Decision
- LYEL Sell
- WNEB Buy
- Analyst Count
- LYEL 2
- WNEB 2
- Target Price
- LYEL $15.00
- WNEB $11.00
- AVG Volume (30 Days)
- LYEL 24.3K
- WNEB 68.7K
- Earning Date
- LYEL 11-06-2025
- WNEB 10-22-2025
- Dividend Yield
- LYEL N/A
- WNEB 2.31%
- EPS Growth
- LYEL N/A
- WNEB N/A
- EPS
- LYEL N/A
- WNEB 0.59
- Revenue
- LYEL $60,000.00
- WNEB $76,036,000.00
- Revenue This Year
- LYEL N/A
- WNEB N/A
- Revenue Next Year
- LYEL N/A
- WNEB $7.36
- P/E Ratio
- LYEL N/A
- WNEB $20.64
- Revenue Growth
- LYEL 11.11
- WNEB 2.15
- 52 Week Low
- LYEL $7.65
- WNEB $7.63
- 52 Week High
- LYEL $32.00
- WNEB $12.70
- Technical
- Relative Strength Index (RSI)
- LYEL 64.71
- WNEB 58.37
- Support Level
- LYEL $12.59
- WNEB $12.02
- Resistance Level
- LYEL $13.50
- WNEB $12.70
- Average True Range (ATR)
- LYEL 0.67
- WNEB 0.21
- MACD
- LYEL 0.18
- WNEB -0.10
- Stochastic Oscillator
- LYEL 76.87
- WNEB 26.47
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.